Effect of fixation period on HER2/neu gene amplification detected by fluorescence in situ hybridization in invasive breast carcinoma

被引:37
作者
Selvarajan, S
Bay, BH
Choo, A
Chuah, KL
Sivaswaren, CR
Tien, SL
Wong, CY
Tan, PH
机构
[1] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore
[2] Singapore Gen Hosp, Dept Gen Surg, Singapore 169608, Singapore
[3] Natl Univ Singapore, Dept Anat, Singapore 117548, Singapore
关键词
FISH; HER2/neu; fixation; breast cancer; immunohistochemistry;
D O I
10.1177/002215540205001215
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This study investigated if formalin fixation duration affects HER2/neu gene amplification detection by fluorescence in situ hybridization (FISH) in breast cancer. Tumor tissues from 35 cases were divided into three groups and subjected to two formalin fixation protocols per group (12 hr, 27 hr in the first; 2 hr, 17.5 hr in the second; 28.5 hr, 541 hr in the third) before FISH analysis. There was no significant difference in FISH signal detection between the two different fixation protocols in the first two groups. In the third, no signal was detected in 4/6 cases fixed for an extended duration.
引用
收藏
页码:1693 / 1696
页数:4
相关论文
共 12 条
[1]   Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma [J].
Couturier, J ;
Vincent-Salomon, A ;
Nicolas, A ;
Beuzeboc, P ;
Mouret, E ;
Zafrani, B ;
Sastre-Garau, X .
MODERN PATHOLOGY, 2000, 13 (11) :1238-1243
[2]   Recommendations for HER2 testing in the UK [J].
Ellis, IO ;
Dowsett, M ;
Bartlett, J ;
Walker, R ;
Cooke, T ;
Gullick, W ;
Gusterson, B ;
Mallon, E ;
Lee, PB .
JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (12) :890-892
[3]   PURIFICATION OF DNA FROM FORMALDEHYDE FIXED AND PARAFFIN EMBEDDED HUMAN-TISSUE [J].
GOELZ, SE ;
HAMILTON, SR ;
VOGELSTEIN, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 130 (01) :118-126
[4]   Fluorescence in situ hybridization: Uses and limitations [J].
Gozzetti, A ;
Le Beau, MM .
SEMINARS IN HEMATOLOGY, 2000, 37 (04) :320-333
[5]   HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma [J].
Hoang, MP ;
Sahin, AA ;
Ordòñez, NG ;
Sneige, N .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (06) :852-859
[6]  
PAULETTI G, 1999, INTRO FLUORESCENCE I, P153
[7]  
Perez EA, 2002, MAYO CLIN PROC, V77, P148
[8]   HER-2/neu testing in breast carcinoma:: A combined immunohistochemical and fluorescence In situ hybridization approach [J].
Ridolfi, RL ;
Jamehdor, MR ;
Arber, JM .
MODERN PATHOLOGY, 2000, 13 (08) :866-873
[9]   Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].
Slamon, DJ ;
Leyland-Jones, B ;
Shak, S ;
Fuchs, H ;
Paton, V ;
Bajamonde, A ;
Fleming, T ;
Eiermann, W ;
Wolter, J ;
Pegram, M ;
Baselga, J ;
Norton, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792
[10]  
THOMPSON CT, 1994, AM J PATHOL, V144, P237